Valuation : DEEPVERGE

Market Cap 8.75M 7.54M 7.11M 6.48M 12.1M 826M 12.19M 84.14M 32.65M 422M 32.84M 32.12M 1.39B P/E 2020
-12.5x
P/E 2021 -19.3x
Enterprise Value 9.18M 7.92M 7.46M 6.8M 12.7M 867M 12.8M 88.32M 34.28M 443M 34.47M 33.72M 1.46B EV / Sales 2020
10x
EV / Sales 2021 6.11x
Free-Float
90.54%
Yield 2020 *
-
Yield 2021 -
5 years 0
Extreme 0.0005
0.34
10 years 0
Extreme 0.0005
0.42
Manager TitleAgeSince
Chief Executive Officer 68 2022-10-31
Director of Finance/CFO - 2018-08-29
Sales & Marketing 52 2021-07-11
Director TitleAgeSince
Chairman 66 2019-05-20
Director/Board Member 68 2020-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
11/16/22 Free

Executive/Senior Manager

162,500 0.0740%
11/16/22 Buy

Chief Financial Officer

2,000,000 0.9103%
11/16/22 Buy

Executive/Senior Manager

650,000 0.2958%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 421K
-0.28%-1.13%+14.13%+14.58% 22.57B
+0.95%-0.72%+16.29% - 14.83B
-4.09%-4.03%+7.62%-23.71% 3.8B
+1.68%+0.17%+41.00%+32.58% 3.03B
-0.49%+0.57%-21.71%-32.68% 2.13B
+0.65%-4.59%-16.13% - 2.04B
-1.65%+1.05%-17.48%+14.92% 1.61B
-1.94%+4.85%-16.25%+4.41% 1.37B
-1.97%-2.90%+50.97%+82.45% 1.35B
Average -0.95%-1.89%+5.84%+11.57% 5.27B
Weighted average by Cap. -0.85%-1.76%+12.39%+11.43%

Financials

2020 2021
Net sales 4.48M 3.87M 3.64M 3.32M 6.2M 423M 6.25M 43.13M 16.74M 217M 16.83M 16.47M 711M 9.3M 8.02M 7.56M 6.88M 12.87M 878M 12.96M 89.45M 34.71M 449M 34.91M 34.15M 1.48B
Net income -2.72M -2.34M -2.21M -2.01M -3.76M -257M -3.79M -26.15M -10.15M -131M -10.21M -9.98M -431M -2.68M -2.31M -2.18M -1.98M -3.71M -253M -3.74M -25.78M -10M -129M -10.06M -9.84M -425M
Net Debt 1.11M 960K 905K 824K 1.54M 105M 1.55M 10.71M 4.16M 53.75M 4.18M 4.09M 177M 434K 374K 353K 321K 601K 41M 605K 4.18M 1.62M 20.96M 1.63M 1.59M 68.86M
Logo DEEPVERGE
Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.
Employees
73